Hudson Value Partners, LLC Bristol Myers Squibb CO Transaction History

Hudson Value Partners, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 29, 2021	SELL	$59.17 - $69.31 $179,107 - $209,801	-3,027 Closed	0 $0
Q2 2021 Jul 09, 2021	SELL	$61.91 - $67.42 $41,665 - $45,373	-673 Reduced 18.19%	3,027 $202,000
Q1 2021 Apr 19, 2021	SELL	$59.34 - $66.74 $29,670 - $33,370	-500 Reduced 11.9%	3,700 $234,000
Q4 2020 Feb 18, 2021	BUY	$57.74 - $65.43 $242,508 - $274,806	4,200 New	4,200 $260,000

2,533

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $125B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Hudson Value Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Hudson Value Partners, LLC with notifications on news.